GSP Neonatal 17 a-OH-progesterone kit

17-Hydroxyprogesterone (17-OHP) - newborn screening · class III · Until 23/06/2035

Registration no.
10298910105
Process no.
25351219537201054
Status
Until 23/06/2035
Device type
17-Hydroxyprogesterone (17-OHP) - newborn screening (17-HIDROXIPROGESTERONA (17-OHP) - TRIAGEM NEONATAL)
Risk class
III
Registration holder
REVVITY DO BRASIL LTDA CNPJ 00.351.210/0001-24 · 194 registrations
Manufacturer
WALLAC OY · Finland
Published
23/06/2010
Valid until
23/06/2035
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other 17-hydroxyprogesterone (17-ohp) - newborn screening registrations (5 in total, see all)

ProductClass HolderPublishedStatus
Neonatal 17-OH-Progesterone FEIA
81541770004
III SUPER DIAGNOSTICA PRODS HOSP LTDA EPP 11/08/2025 Until 11/08/2035
17 alfa-OH Progesterona Test System – ELISA
80048490105
III USA DIAGNOSTICA LTDA 12/05/2025 Until 12/05/2035
IMUNOSCREEN NEO 17-OHP DBS
80047580220
III MBIOLOG DIAGNÓSTICOS LTDA 14/02/2024 Until 14/02/2034
KIT DELFIA AUTODELFIA 17 ALFA-HIDROXIPROGESTERONA NEONATAL
10298910015
III REVVITY DO BRASIL LTDA 23/09/1996 Until 23/09/2036